Yi, Jun Ho
Yoon, Dok Hyun
Park, Sung‑Soo
Min, Chang‑Ki
Lee, Ji Hyun
Jung, Sung‑Hoon
Koh, Youngil
Lee, Hyun Jung
Jo, Jae-Cheol
Kim, Kihyun
Article History
Received: 21 October 2025
Accepted: 20 January 2026
First Online: 6 February 2026
Declarations
: All procedures involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committees, as well as with the Declaration of Helsinki or comparable ethical standards. The exemptions of obtaining the informed consents were approved by the institutional review board of each institute. This study was approved by the institutional review boards of each participating site (SMC 2024–03-048; KC24RIDI0380; SNUH-2408–026-1558; AMC2024-0825; CNUHH-2025–077; DAUH IRB-24–085; UUH IRB 2024–03-039; KHUH IRB 2025–04-051) and carried out by the Korean Multiple Myeloma Working Party (KMM-2401 trial). All authors declare no competing interests.
: The authors declare no competing interests.